Study aims to demystify the immune toxicity triggered by osimertinib-ICI co-treatment – Diabetes Prevention Awareness Center

Study aims to demystify the immune toxicity triggered by osimertinib-ICI co-treatment

Post author:admin
Post published:June 6, 2025
Post category:uncategorized
Post comments:0 Comments

Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases and remains a leading cause of cancer mortality worldwide.

Leave a Reply Cancel reply

You must be logged in to post a comment.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

© 2025 Diabetes Prevention Awareness Center.